Literature DB >> 21245641

A case of Takayasu's arteritis associated with human leukocyte antigen A24 and B52 following resolution of ulcerative colitis and subacute thyroiditis.

Yoshiro Horai1, Tomoya Miyamura, Karin Shimada, Soichiro Takahama, Rumi Minami, Masahiro Yamamoto, Eiichi Suematsu.   

Abstract

A 46-year-old female with a past history of ulcerative colitis (UC) was diagnosed with subacute thyroiditis (SAT), which improved with prednisolone (PSL) treatment (60 mg/day). The dose of PSL was gradually decreased, however upper back and neck pain and chest discomfort developed. The patient was diagnosed with Takayasu's arteritis (TA) based on wall thickening and luminal narrowing of the left common carotid artery and the left subclavian artery. The result of human leukocyte antigen typing analysis was A24 and B52 positive. These findings suggested that common genetic factors may be important for the etiology of TA, UC and SAT. This is the first report of TA that developed following UC and SAT.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21245641     DOI: 10.2169/internalmedicine.50.4385

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

Review 1.  Association of STAT4 gene rs7574865G > T polymorphism with ulcerative colitis risk: evidence from 1532 cases and 3786 controls.

Authors:  Ling Xu; Wei-Qi Dai; Fan Wang; Lei He; Ying-Qun Zhou; Jie Lu; Xuan-Fu Xu; Chuan-Yong Guo
Journal:  Arch Med Sci       Date:  2014-06-27       Impact factor: 3.318

2.  Takayasu arteritis associated with ulcerative colitis and optic neuritis: first case in Korea.

Authors:  Jung Yoon Pyo; Jin Su Park; Chang Ho Song; Sang Won Lee; Yong Beom Park; Soo Kon Lee
Journal:  Korean J Intern Med       Date:  2013-07-01       Impact factor: 2.884

Review 3.  Concomitant Thyroid Disorders and Inflammatory Bowel Disease: A Literature Review.

Authors:  Toru Shizuma
Journal:  Biomed Res Int       Date:  2016-03-03       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.